Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT02141139 Not yet recruiting - Breast Neoplasms Clinical Trials

Perioperative Inflammation and Breast Cancer Outcome

Start date: September 2014
Phase: Phase 3
Study type: Interventional

It is increasingly recognized the NSAIDS (nonsteroidal antiinflammatory drug) might prevent the several cancers. In breast cancer, the role of NSAIDS (nonsteroidal antiinflammatory drug) has been suggested.However, there was no consistent results. surgery is main cause of inflammation for cancer patients. Therefore, we want to know the association between prevention of perioperative inflammation with NSAIDS and breast cancer outcomes.

NCT ID: NCT02096640 Not yet recruiting - Inflammation Clinical Trials

Postoperative Inflammation and Recovery After Tracheostomy

Start date: March 2014
Phase: N/A
Study type: Interventional

The main purpose of this study is to examine if there are differences in postoperative inflammation following percutaneous dilatation tracheostomy versus surgical tracheostomy in intensive care unit patients.

NCT ID: NCT01750801 Not yet recruiting - Inflammation Clinical Trials

Efficacy of a Mouthwash Containing Propolis

PRO
Start date: February 2013
Phase: Phase 3
Study type: Interventional

Characterization of green propolis and development of mouthwash containing propolis to control plaque and gingivitis. A Phase I.

NCT ID: NCT01618201 Not yet recruiting - Inflammation Clinical Trials

Inflammatory Markers Identification in Migraine Patients

Start date: June 2012
Phase: N/A
Study type: Observational

Migraine is prevalent in 10-12% of the population. It involves the development of a cranial perivascular neurogenic inflammation. Recent information suggests that migraine might be a risk factor to stroke. The possible mechanisms that might relate migraine and stroke are: 1. Migraineous infarction 2. A primary endothelial disorder. 3. Genetic relation 4. An ongoing inflammatory process. C reactive protein (CRP) is a sensitive marker for an inflammatory process.The data on the relation of migraine to inflammation is limited. The aim of the current study is to assess inflammatory factors as possible markers for migraine.

NCT ID: NCT01603030 Not yet recruiting - Clinical trials for Eye Infection/Inflammation Other

Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation

Start date: June 2012
Phase: Phase 3
Study type: Interventional

This is a Unicentric, double-blind, randomized, two-arm, parallel-group study to demonstrate the efficacy of moxifloxacin/prednisolone acetate fixed combination compared with individual administration of moxifloxacin + acetate Prednisolone Eye drops in Prevention of Post Operative Inflammation and Infection in LASIK surgery.

NCT ID: NCT01553513 Not yet recruiting - Clinical trials for Coronary Artery Disease

PET/CT for the Quantification of Atherosclerotic Plaque Inflammation

QAEK
Start date: June 2012
Phase: N/A
Study type: Observational

This is a single-centre prospective trial with 140 patients employing [18F]-fluorodeoxyglucose positron emission computed tomography (FDG PET/CT) and advance motion correction and image fusion algorithms to create motion frozen displays and quantify FDG-uptake and thus inflammatory activity in atherosclerotic plaques in the coronary tree. Four groups of patients, two with stable coronary artery disease and two with acute coronary syndrome will be compared and the results of FDG PET/CT will be correlated to results of invasive coronary angiography, intravascular ultrasound / virtual histology, patient risk profile and serum markers of inflammation. The investigators hypothesize that increased FDG accumulation in atherosclerotic plaques shows a positive correlation with inflammatory activity in coronary plaques and markers of plaque vulnerability as well as the risk profile of the patients and serum markers of inflammation. The investigators furthermore hypothesize that FDG PET/CT is able to detect high risk patients and provide an important means for risk stratification and optimization of patient management.

NCT ID: NCT01502826 Not yet recruiting - Inflammation Clinical Trials

Mechanisms of Atherogenesis During Post-prandial Time in Childhood Obesity

Start date: February 2012
Phase: N/A
Study type: Observational

Childhood obesity is increasing at a fast pace, together with its complications. The aim of the present study is to assess several candidate triggering agents, mechanisms and intermediate phenotypes of atherosclerosis during the post-prandial phase in the obese insulin-resistant child/adolescent.

NCT ID: NCT01332526 Not yet recruiting - Obesity Clinical Trials

FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).

Start date: May 2011
Phase: N/A
Study type: Observational

Fructose intake from added sugars has increased dramatically over the last century and has recently been implicated as potential contributor to metabolic syndrome, obesity, hypertension, inflammation and kidney disease. Fructose differs from the other sugars because, uric acid is generated during its metabolism. Serum uric acid levels have been found to correlate with the intake of fructose and added sugars. In turn, an elevated serum uric acid has also been shown to be associated with increased risk for cardiovascular and metabolic diseases. On the other hand complexity of fructose metabolism in each individuals results of the various magnitude of hyperuricemia induced by fructose intake. The magnitude of uric acid production in each patient may reflect individual predisposition to endogenous urate production in a face of relatively normal fasting uric acid concentration. Therefore the oral fructose tolerance test might reveal an occult purine disturbances which plays casual role in either metabolic disturbances or organ damage. The aim of this study is to see whether is a relationship between fructose induced hyperuricemia and metabolic disturbances , inflammatory state and organ damage in obese and various stages CKD patients.

NCT ID: NCT01202812 Not yet recruiting - Quality of Life Clinical Trials

A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)

Start date: October 2010
Phase: Phase 2
Study type: Interventional

The purpose of the study is to determine the effectiveness of LOVAZA (fish oil capsules) to decrease inflammation in children and adolescents with Sickle Cell Disease (SCD). It has been found that besides the damage caused by sickle red blood cells themselves, the inflammatory response that occurs in SCD patients could potentially play a significant role in the occurrence of painful episodes or pain crises. The investigators will also study whether the subject/caregiver feels that there is an improvement in the child's quality of life by taking the medication. Besides the effect of LOVAZA on inflammation,the investigators are also testing whether the drug will have a beneficial effect on blood clotting ability (which is known to be increased in SCD) and on the anemia (low red blood cells) that is part of the disease entity.

NCT ID: NCT01101204 Not yet recruiting - Diabetes Clinical Trials

The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines

MSF
Start date: July 2012
Phase: N/A
Study type: Interventional

The study is planned to show whether combined hypolipemic and antidiabetic therapy with various daily dosages influence the fasting plasma glucose, insulin sensitivity and proinflammatory cytokines in diabetic and dyslipidemic subjects.